Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07251790Not ApplicableRecruiting

Optimising Breathing Support at Extubation in Very Preterm Infants: A Clinical Study

Role: collaborator

NCT07101419Not ApplicableNot Yet Recruiting

Speed of Lung Inflation During Ventilation of Extremely Preterm Infants

Role: collaborator

NCT02140580Phase 4Unknown

OPTIMIST-A Trial: Minimally-invasive Surfactant Therapy in Preterm Infants 25-28 Weeks Gestation on CPAP

Role: collaborator

All 3 trials loaded